'김갑성' 기자의 전체기사
-
United Imaging Marks Five Years Since the Opening of its Glob…
[ 메디채널 김갑성 기자 ] The company launched American R&D in 2013 and American commercial operations in 2018; in 2020 it opened a 100,000 square foot production and training center in Houston, and just tripled its local footprint to support strong growth. HOUSTON, Oct. 19, 2025 -- United Imaging, a global manufacturer of modern medical imaging technology, saw a record number of visits to its North American hub from U.S. healthcare providers in one week in October, and an overall spike in 2025. The nearly 100,000 square foot facility first opened its doors in Houston in 2020, and
- 김갑성 기자
- 2025-10-19 22:00
-
Multitude Therapeutics Announces Encouraging Interim Ph…
[ 메디채널 김갑성 기자 ] AMT-253 is a potential first-in-class MUC18-directed ADC with a proprietary linker-payload design AMT-253 demonstrated a manageable safety profile, consistent with other TOP1-inhibitor based ADCs Promising antitumor activity was observed in heavily pretreated patients with melanoma and gynecologic cancers without MUC18 preselection SHANGHAI, Oct. 19, 2025 -- Multitude Therapeutics, Inc., a clinical stage biopharmaceutical company focused on the development of ADC drugs, today announced interim results from its ongoing Phase I/II open-label, multicente
- 김갑성 기자
- 2025-10-19 15:00
-
Case Report | Preliminary Clinical Data of CARsgen's Allogenei…
SHANGHAI, Oct. 19, 2025 -- Primary plasma cell leukemia (pPCL) is a rare and highly aggressive plasma cell malignancy, often associated with complex genetic abnormalities. There is currently no standard treatment regimens, and conventional therapies for multiple myeloma are typically used. While targeted agents and autologous hematopoietic stem cell transplantation can slightly extend the overall survival of pPCL patients to 1.5–3 years, relapsed/refractory pPCL after multiple lines of therapy presents a significant clinical challenge due to the extremely limited treatment options and
- 김갑성 기자
- 2025-10-19 14:00
-
From Wellbeing to Academics: Why HK Parents Are Hitting Paus…
[ 메디채널 김갑성 기자 ] Look Up Hong Kong-Ipsos survey of 651 parents backs a four-part plan for kids' wellbeing: delayed access to smartphones and social media, phone-free schools and more real-world activity and experiences. HONG KONG, Oct. 19, 2025 -- Look Up Hong Kong, a new parent-led group launched to unite families for healthier, happier childhoods in the digital age, is leading a movement to advocate for delayed smartphone and social media use. The movement is backed by a growing global body of medical research, and now by Hong Kong data showing overwhelming support from local fami
- 김갑성 기자
- 2025-10-19 13:00
-
Kelun-Biotech Presents Positive Results of Phase 3 Clinical S…
CHENGDU, China, Oct. 18, 2025 -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that at the 2025 European Society for Medical Oncology (ESMO) Congress held in Berlin, Germany, results from a Phase 3 OptiTROP-Breast02 study of the Company's trophoblast cell-surface antigen 2 (TROP2)-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) (佳泰莱®) in previously treated locally advanced or metastatic hormone receptor-positive (HR+) and human epidermal growth factor receptor 2 -negative (HER2-) breast cancer (BC) was presented as a
- 김갑성 기자
- 2025-10-18 22:46
-
Manulife Hong Kong and JUST FEEL Promote Emotional Well-Be…
[ 메디채널 김갑성 기자 ] 500 family volunteers distribute over 10,000 free flags to encourage the public to share their feelings HONG KONG, Oct. 18, 2025 -- Manulife Hong Kong and JUST FEEL, a Hong Kong-based NGO dedicated to emotional education, successfully held the city's first-ever "My Flag Day" today. A total of 500 family volunteers from Manulife and nine of JUST FEEL's partner schools engaged with 10,000 citizens across the city, encouraging them to select a flag to wear, which would represent their current feelings. This initiative aims to raise public awareness of self-care
- 김갑성 기자
- 2025-10-18 16:23
-
Research Updates on a Phase III Clinical Trial of Anbenitama…
SUZHOU, China, Oct. 18, 2025 -- Alphamab Oncology (Stock Code: 9966.HK) announced that the first interim analysis results of a phase III clinical trial of anbenitamab injection (KN026), independently developed by the Company and co-developed with JMT-Bio Technology Co., Ltd., a wholly-owned subsidiary of CSPC Pharmaceutical Group Co., Ltd. (stock code: 1093.HK), in combination with chemotherapy as second-line or above treatment of HER2-positive gastric cancer (GC) (including gastroesophageal junction cancer (GEJ)) (Study ID: KN026-001, also known as KC-WISE), have been presented at the 2025 E
- 김갑성 기자
- 2025-10-18 14:59
-
SCG announces presentation of clinical results of SCG142 in…
SINGAPORE, Oct. 18, 2025 -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing next-generation immunotherapies for infectious diseases and their associated cancers, announced the presentation of first-in-human clinical data for SCG142 in an investigator-initiated Phase I trial (NCT06544720) in patients with recurrent or metastatic HPV-associated carcinomas. The poster will be presented at the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin, Germany, on Saturday, 18 October 2025. This ongoing first-in-human trial evaluates the safety,
- 김갑성 기자
- 2025-10-18 13:00
-
One Heung Kong released the White Paper on Global Susta…
GUANGZHOU, China, Oct. 18, 2025 -- On October 14, the 2025 Global Engineering Conference and the first World Green Design Conference opened in Shanghai, China, drawing together over 250 former senior UN officials, academicians from different countries, and representatives from Fortune 500 companies. At the event, the White Paper on Global Sustainable and Healthy Living Environments (the Global Healthy Living Environment Report) was unveiled, setting a fresh yardstick for fostering healthy living across the globe. With the rapid pace of global urbanization, traditional residenti
- 김갑성 기자
- 2025-10-18 11:06
-
Avathon、航空宇宙事業向け自律プラットフォームを発表
[ 메디채널 김갑성 기자 ] 自律プラットフォームはコックピットから製造現場、格納庫、サプライチェーンへと拡大、航空宇宙事業を変革 カリフォルニア州プレザントン（米国）, 2025年10月17日 -- Avathonは本日、航空宇宙事業向け[ 메디채널 김갑성 기자 ] 自律プラットフォーム「Autonomy for Aerospace Operations」の発売を発表しました。これは製造、サプライチェーン、保守データを統合するAIナレッジプラットフォームであり、航空宇宙ライフサイクル全体にわたる協調的な意思決定を推進するものです。 同時に、このプラットフォームは生産品質、部品表（BOM）、サプライヤー調達、部品在庫状況、および労働供給力からの知見を統合することで、製造や物流における判断と運用中の整備や修理業務の同期を可能にすることから、即座に部品調達や修理が必要となる地上繋止機（AOG）事象の削減、処理能力と品質の向上、および機材運用準備態勢の強化につながるものでもあります。 航空宇宙業界では、運用面での圧力がますます増大しています。航空会社や運航事業者は、老朽化しつつある機体を維持しながら複雑なネットワーク系統を修復する必要があります。一方、委託製造業者（OEM）は妥協が許されない品質基準を満足しながら生産
- 김갑성 기자
- 2025-10-17 22:50
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 5아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 6하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 7대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2025-12-12_FRI
- ADSFF Mobilises Capital, Policy and Innovation to Drive the Next Era of Sustainability 02:42
- His Excellency affirmed that NDF has achieved significant international development milestones over the past fifty years, including more than USD 40 billion in assistance 01:35
- ZOWIE Elevates Esports Performance at Budapest Major 2025 01:00
- TraceLink Supports UNICEF's Traceability and Verification System (TRVST) to Advance Safe, Authentic Medicine Access Globally 00:21
- ACE Shutters Notorious Piracy Operations in India 00:01
- Suvoda IRT named a Leader in Everest Group's RTSM PEAK Matrix® 00:00
- Gravity Launches Hybrid Casual Game 'Ragnarok Monster Kitchen' Worldwide! 00:00
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2025년 12월 12일 04시 20분